Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PEGFILGRASTIM-APGF for Bone cancer: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 6 adverse event reports in the FDA FAERS database where PEGFILGRASTIM-APGF was used for Bone cancer.

Most Reported Side Effects for PEGFILGRASTIM-APGF

Side Effect Reports % Deaths Hosp.
Death 18 15.0% 16 0
Device leakage 9 7.5% 0 0
Drug dose omission by device 9 7.5% 0 0
Pyrexia 8 6.7% 0 8
Off label use 6 5.0% 1 0

Other Indications for PEGFILGRASTIM-APGF

Neutropenia (9) Breast cancer female (5) Neoplasm malignant (5)

Other Drugs Used for Bone cancer

PALBOCICLIB (493) LENALIDOMIDE (342) CABOZANTINIB S-MALATE (328) DENOSUMAB (219) ENZALUTAMIDE (213) PAZOPANIB (182) ERLOTINIB (174) CAPECITABINE (143) BEVACIZUMAB (140) POMALIDOMIDE (114)

Related Pages

PEGFILGRASTIM-APGF Full Profile All Bone cancer Drugs PEGFILGRASTIM-APGF Demographics PEGFILGRASTIM-APGF Timeline